Has Peter McCullough received payments from drug or device companies?

Yes. Drug and device makers reported $1,132,992 in general payments to Peter McCullough across 1,101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter McCullough did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter McCullough come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter McCullough

Cardiovascular Disease · Dallas, TXNPI 1386604700

Payments from drug & device makers

$1,132,992in general payments, 2019–2025

Across 1,101 payments — averaging $1029.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$269K
Amgen$134K
Boehringer Ingelheim International GmbH$110K
Sanofi-aventis U.S. LLC$107K
Novo Nordisk AS$81K
Merck$53K
plus $378K from 47 others

$5,700in research payments, 2019–2025

Across 4 payments — averaging $1425.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novo Nordisk AS$6K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	142	$269,435
Amgen	71	$133,702
Boehringer Ingelheim International GmbH	203	$109,595
Sanofi-aventis U.S. LLC	108	$107,481
Novo Nordisk AS	173	$81,209
Merck	47	$53,200
Boehringer Ingelheim Pharma GmbH & Co.kg	18	$38,068
Bayer	45	$36,003
Novo Nordisk	28	$31,161
Sanofi US Services Inc.	18	$29,749
Novartis	17	$26,880
Edwards Lifesciences	21	$22,124
Akebia Therapeutics Inc	2	$17,980
Nxstage Medical, Inc.	17	$16,916
GE HealthCare	13	$15,381
Lilly USA, LLC	10	$15,336
Eli Lilly	5	$14,700
Boehringer Ingelheim	15	$14,071
Astrazeneca AB	15	$11,793
Mallinckrodt Hospital Products Inc.	1	$10,800
Janssen Research & Development, LLC	1	$10,000
Astrazeneca UK Limited	11	$9,527
Amryt Pharma Holdings Ltd	18	$9,080
Johnson & Johnson	13	$6,609
Baxter Healthcare	6	$5,996
Abbott	5	$5,895
Quidel Corporation	8	$4,943
Aegerion Pharmaceuticals, Inc.	2	$4,497
Chiesi USA, Inc.	2	$3,833
Mallinckrodt Enterprises LLC	3	$3,741
Rockwell Medical, Inc.	1	$3,000
Regeneron	2	$2,758
Esperion Therapeutics, Inc.	4	$2,394
Instrumentation Laboratory Company	1	$1,700
Regeneron Healthcare Solutions, Inc.	4	$1,498
Nuwellis, Inc.	2	$921
Corium, LLC	14	$225
Amarin Pharma, Inc.	9	$205
Amicus Therapeutics, Inc.	4	$79
Alnylam Pharmaceuticals Inc.	3	$77
Lexicon Pharmaceuticals, Inc.	1	$64
E.r. Squibb & Sons, L.L.C.	4	$63
Potrero Medical, Inc.	1	$50
AbbVie	3	$47
Abiomed	1	$37
GSK	2	$35
Corcept Therapeutics	1	$33
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Sanofi	1	$21
Idorsia Pharmaceuticals US Inc	1	$17
Azurity Pharmaceuticals, Inc.	1	$16
Lantheus Medical Imaging, Inc.	1	$16
Medicure Pharma Inc.	1	$11

How this compares

$1,132,992 in reported general payments places this provider in the 95th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Other cardiovascular disease in Dallas

Ramin Farzaneh-FarDallas$17.1M
Jeffrey GladdenDallas$15.8M
Ann NavarDallas$14.5M
Justin GrodinDallas$6.2M
Ambarish PandeyDallas$2.9M
Paul GrayburnDallas$1.8M
Parag KaleDallas$1.5M
Eric PetersonDallas$1.4M
Parag JoshiDallas$1.4M
Darren McGuireDallas$1.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →